Stock comparison
InMode
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
INMD
InMode
Market cap
$870.55M
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | INMD | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 56C | 77B | LMAT |
| Benjamin Graham | 52C | 89A | LMAT |
| Philip Fisher | 46D | 81C | LMAT |
| Peter Lynch | 24F | 67B | LMAT |
| Joel Greenblatt | 27F | 56D | LMAT |
| Charlie Munger | 58C | 68D | LMAT |
| Terry Smith | 59C | 69D | LMAT |
Side-by-side metrics
| Metric | INMD | LMAT |
|---|---|---|
| Market cap | $870.55M | $2.23B |
| P/E (TTM) | 10.0x | 37.1x |
| EV/EBIT | 5.6x | 36.6x |
| ROIC (TTM) | 10.11% | 9.43% |
| Gross margin | 77.84% | 72.39% |
| Net margin | 23.27% | 24.35% |
| Revenue CAGR 5y | 0.89% | 12.75% |
| EPS CAGR 5y | -8.07% | 19.04% |
| Debt / Equity | 0.0x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
INMD leads on
- Debt / Equity0.0xvs 0.5x+98%
- EV/EBIT5.6xvs 36.6x+85%
- P/E (TTM)10.0xvs 37.1x+73%
- Gross margin77.84%vs 72.39%+7%
LMAT leads on
- EPS CAGR 5y19.04%vs -8.07%+142%
- Dividend yield0.84%vs 0.0%+100%
- Revenue CAGR 5y12.75%vs 0.89%+93%
- Market cap$2.23Bvs $870.55M+61%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.